Tirzepatide, weight and testosterone

Why extra weight lowers testosterone

In a review in the Journal of Clinical Endocrinology and Metabolism, obesity was described as the strongest risk factor for low testosterone in middle-aged and older men. In the European Male Aging Study, a gain of 4 to 5 BMI units was linked to a testosterone drop comparable to ten years of aging.

Typically the luteinizing hormone (LH) signal from the pituitary is not raised, which points to suppression from above rather than testicular damage. This is often called functional or obesity-related hypogonadism. Insulin resistance, central belly fat, poor sleep and sleep apnea all appear to contribute.

What weight loss does

Because the system is suppressed rather than broken, it can recover. The same review summarized the size of the effect:

• Diet-related weight loss averaging about 10% raised total testosterone by about 84 ng/dL.
• In men who lost more than 15% of their weight, total testosterone rose by about 164 ng/dL, with LH and free testosterone also increasing.
• Weight-loss surgery averaging about 32% raised total testosterone by about 251 ng/dL.
• Weight loss also improved erectile function, though less than medicines like tadalafil.

Where tirzepatide fits

Tirzepatide is approved for chronic weight management and for obstructive sleep apnea in adults with obesity. It is not approved to treat low testosterone. Its relevance is indirect: it can produce the kind of weight loss linked with meaningful testosterone recovery, and it can improve sleep apnea, another suppressor of testosterone.

Research specifically on incretin medicines and testosterone is growing. Recent reviews describe promising effects of GLP-1 medicines on testosterone and erectile function in men with obesity, but most studies are small, short or observational. A 2026 systematic review called the relationship between testosterone deficiency and response to these drugs incompletely understood.

A sensible order of steps

• Confirm the problem: symptoms plus low morning fasting testosterone on at least two tests, as the Endocrine Society recommends.
• Find the type: LH and FSH help separate testicular (primary) from brain-signal (secondary) causes.
• Look for drivers: weight, blood sugar, sleep apnea, medicines such as opioids, and alcohol.
• Treat what is reversible: weight, sleep and contributing medicines.
• Recheck testosterone after significant weight loss; if symptoms and low levels persist, consider testosterone therapy.

When this approach does not apply

If LH and FSH are high, the testes themselves are not responding, and weight loss will not fix that. Very low levels, pituitary problems or symptoms such as loss of body hair or shrinking testes need a fuller evaluation.

Lean men with low testosterone also fall outside this logic. And some men with obesity have symptoms severe enough that starting testosterone alongside a weight program, rather than waiting, is reasonable. The JCEM review supports either starting testosterone during a lifestyle trial or after it fails, with a tailored workup and counseling.

Combining tirzepatide and testosterone therapy

There is no rule against using both, and some men do. Testosterone therapy has its own requirements: the Endocrine Society advises against it for men planning fertility soon, with prostate or breast cancer, an elevated hematocrit, untreated severe sleep apnea, uncontrolled heart failure or a heart attack or stroke in the past six months. It also requires PSA and hematocrit monitoring, and it suppresses sperm production.

Tirzepatide brings its own cautions: a boxed warning about thyroid C-cell tumors in rats, with no use if you or a family member has had medullary thyroid carcinoma or if you have MEN 2, plus stomach side effects, pancreatitis and gallbladder risks. Losing a lot of weight quickly can also cost muscle, which strength training and protein help protect.

How HealifyMD approaches it

We start with a proper hormone workup, including repeat morning testosterone, LH, FSH, SHBG, estradiol and metabolic labs; the comprehensive lab panel is $199. Your clinician then lays out the options and the order that fits you.

Compounded tirzepatide is from $399/month ($750 for 2 months, $375/month). It is not FDA-approved, has not been reviewed by the FDA for safety, effectiveness or quality and is not equivalent to Zepbound. Testosterone replacement therapy is $249 the first month, including the lab panel, then $149/month, or $450 for 3 months of refills. All prices are confirmed at the eligibility review.